Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Molecular basis of USP7 inhibition by selective small-molecule inhibitors
is rapidly cleaved to release the active form Olmesartan (RNH-6270)
Smiles: C[C@@H](O)[C@H](NC(=O)C1=CC=C(C=C1)C#CC1=CC=C(CN2CCOCC2)C=C1)C(=O)NO
Cilomilast reduces TLR4 expression
Daily HepG2 tumor growth of WAY-600-administrated mice is significantly lower than that of vehicle control mice
Fedratinib hydrochloride hydrate ((2S)-1 2-propanediol hydrate) Molecular basis of USP7 inhibitionFedratinib hydrochloride hydrate (TG 101348 hydrochloride hydrate) is a potent, selective, ATP competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. Fedratinib hydrochloride hydrate shows 35 and 334 fold selectivity over JAK1 and JAK3, respectively. Fedratinib hydrochloride hydrate induces cancer cell apoptosis and has the potential for myeloproliferative disorders research. Product information CAS Number:
US$ 171.00
US$ 10.00
US$ 179.00
US$ 550.00
US$ 250.00
US$ 199.50
US$ 18.00
US$ 213.30
US$ 151.00
US$ 262.50
US$ 65.32
US$ 250.00
US$ 44.91